CSNK1A1L Activators

The indirect activators of CSNK1A1L listed above target various signaling pathways and cellular processes that are connected to the functional roles of CSNK1A1L. Wnt agonists and GSK-3 inhibitors, by modulating Wnt/β-catenin signaling, can have an indirect effect on CSNK1A1L, which is known to play a role in this pathway.

Lithium, a known GSK-3 inhibitor, can modulate Wnt signaling, thereby impacting the activity of CSNK1A1L. Forskolin, by increasing cAMP levels, activates adenylate cyclase, influencing various signaling pathways, including those that CSNK1A1L may be involved in. 3AMPK activators like Metformin can modulate cellular energy balance and signaling pathways, affecting CSNK1A1L's role in these processes. Similarly, mTOR and PI3K/Akt activators can influence signaling pathways that might intersect with CSNK1A1L's functions. Lastly, compounds that modulate circadian rhythms could indirectly influence CSNK1A1L, given its involvement in the regulation of these rhythms.